Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 50268-190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50268-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (8b931a82 Figure 01)

FDA Label Image

Label 5026819015 Cyclobenzaprine Hci 5mg

Label 5026819015 Cyclobenzaprine Hci 5mg
This is a description of a medication with NDC number 50268-190-15. The medication is Cyclobenzaprine Hydrochloride which is available as a USP tablet. The medication is available only on prescription, and it comes in a unit dose of 50 tablets (5x 10). The normal adult dosage is specified in the product information that comes along. It is important to store the medication in a controlled room temperature of 20° to 25°C (68° to 77°F). The medication is manufactured by AVKARE, Inc in Pulaski, TN, 38478. It is important to keep the medication out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.